跳到正文
原文
Amgen 🧪🔬🧬· @Amgen · X·· 12 天前AI 评分42
AI 导读

📢 安进真实世界研究显示,降低LDL-C的治疗决策影响ASCVD患者的心脏病发作风险。 这些发现促使我们重新审视临床实践中降低LDL-C的方式。 🔗 https://amgen.ly/47Z4v6A $AMGN

正文

📢 Amgen’s real-world study shows that treatment decisions to lower LDL-C impacts heart attack risk in ASCVD patients.

The findings prompt a closer look at how we approach LDL-C lowering in clinical practice.

🔗 https://amgen.ly/47Z4v6A

$AMGN

来源:Amgen 🧪🔬🧬 · x.com